Edotreotide

Edotreotide is an Indicator and Reagent. Edotreotide bound to various radionuclides, has the potential for the research and diagnosis of certain types of cancer.


Cat. No.: EX-A4065	Purity: >98%

	Chemical structure of Edotreotide

For research only, Do not use for Human!

Size	Unit Price (US$)	Stock
50mg	625	In-stock
100mg	965	In-stock
250mg	1385	In-stock
500mg	1985	In-stock
1g	2785	In-stock

Send PO to E-mail:[email protected]; or Fax:+86 020 81619670

Discount Request


Synonyms	DOTATOC
Synonyms 2	SMT 487
CAS No.	204318-14-9
Purity	>98%
Formula	C65H92N14O18S2
Mol Weight	1421.639
State	solid powder
Solubility	H2O : 5 mg/mL (3.52 mM; ultrasonic and warming and heat to 60?)
Shelf Life	>2 years if stored properly
Storage	Powder -20℃ 1 year; In solvent -20℃ 1 month;
Shipping	Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Reference:	[1]. Norenberg JP, et al. 213Bi-[DOTA0, Tyr3]octreotide peptide receptor radionuclide therapy of pancreatic tumors in a preclinical animal model. Clin Cancer Res. 2006;12(3 Pt 1):897-903. [2]. Baum, Richard P et al. Clinical evaluation of the radiolanthanide terbium-152: first-in-human PET/CT with 152Tb-DOTATOC. Dalton transactions (Cambridge, England : 2003) vol. 46,42 (2017): 14638-14646. [3]. Maybody, Majid et al. Ga-68 DOTATOC PET/CT-Guided Biopsy and Cryoablation with Autoradiography of Biopsy Specimen for Treatment of Tumor-Induced Osteomalacia. Cardiovascular and interventional radiology vol. 39,9 (2016): 1352-7.
CoA	CoA of Edotreotide

Smiles:	C[C@H]([C@H]1C(=O)N[C@@H](CSSC[C@@H](C(=O)N[C@H](C(=O)N[C@@H](C(=O)N[C@H](C(=O)N1)CCCCN)CC2=CNC3=CC=CC=C32)CC4=CC=C(C=C4)O)NC(=O)[C@@H](CC5=CC=CC=C5)NC(=O)CN6CCN(CCN(CCN(CC6)CC(=O)O)CC(=O)O)CC(=O)O)C(=O)N[C@H](CO)[C@@H](C)O)O


		Search